- Approval Id
- ec4468d77bcd4240
- Drug Name
- IOPAMIRO 300 INJECTION 6.12 G/10 ML
- Product Name
- IOPAMIRO 300 INJECTION 6.12 G/10 ML
- Approval Number
- SIN05906P
- Approval Date
- 1991-05-22
- Registrant
- DCH AURIGA SINGAPORE
- Licence Holder
- DCH AURIGA SINGAPORE
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- INJECTION
- Dosage
- <p><strong>NEURORADIOLOGY</strong></p>
<img src="/TGIF/Iopamiro-Table1_211123.png" alt="Iopamiro Dosage Table 1" /><br><br>
<p><strong>ANGIOGRAPHY</strong></p>
<img src="/TGIF/Iopamiro-Table2_211123.png" alt="Iopamiro Dosage Table 2" /><br><br>
<p><strong>UROGRAPHY</strong><br>
Iopamiro 300 and 370 should be used; the dose recommended for this type of examination is 30 to 50 ml.<br>
The less marked osmotic diuresis induced by the nonionic agent makes Iopamiro 370 especially suitable for patients with mild or moderately severe renal insufficiency and for neonates. The new contrast medium affords diagnostically useful nephrography even in patients with major renal insufficiency.</p>
<p><strong>OTHER DIAGNOSTIC PROCEDURES</strong></p>
<img src="/TGIF/Iopamiro-Table3_211123.png" alt="Iopamiro Dosage Table 3" /><br><br>
<p>For the enhancement of contrast in CT scans Iopamiro may be injected intravenously as a bolus, as a drip infusion or by a combination of the two methods.</p>
- Route Of Administration
- INTRAVENOUS, OTHERS
- Indication Info
- <p><strong>INDICATIONS</strong><br>
<em>NEURORADIOLOGY:</em> myeloradiculography, cisternography and ventriculography.<br>
<em>ANGIOGRAPHY:</em> cerebral arteriography, coronary arteriography, thoracic aortography, abdominal aortography, angiocardiography, selective visceral arteriography, peripheral arteriography, venography, digital subtraction angiography (DSA), DSA of cerebral arteries, DSA of peripheral arteries, DSA of abdominal arteries.<br>
<em>UROGRAPHY:</em> intravenous urography.<br>
<em>CONTRAST ENHANCEMENT IN CT SCANNING</em>. <em>ARTHROGRAPHY</em>. <em>FISTULOGRAPHY</em>.</p>
- Contraindications
- <p><strong>CONTRAINDICATIONS</strong><br>
There are no definite or absolute contraindications to the use of Iopamiro, with the possible exception of Waldenström's macroglobulinemia, multiple myeloma, and severe liver and kidney diseases.</p>
- Atc Code
- V08AB04
- Atc Item Name
- iopamidol
- Pharma Manufacturer Name
- DCH AURIGA SINGAPORE
